top of page

PROJECTS

CHAIN

The CHAIN project (Collaborative HIV and Anti-HIV Drug Resistance Network) aims at effectively and durably combat new and existing anti-HIV drug resistance in clinical settings, with a special emphasis on Eastern Europe and in heavily affected resource-poor regions in Africa. This will be achieved through a pan-European network of surveillance and basic research activities, the involvement of all main actors in the field of HIV and anti-HIV drug resistance, monitoring how resistances develop and evolve, improved understanding of mechanisms of resistance development, performing molecular epidemiology studies, providing improved and new strategies to evaluate and limit the emergence and transmission of HIV drug resistance, setting up training and dissemination activities and supporting evidence-based public health policy and action.

EuResist Network is responsible for main deliverables in Work Package 4 " MOLECULAR EPIDEMIOLOGY AND BIOINFORMATICS CLUSTER".

CHAIN Consortium

Duration: 01/02/09 – 31/03/14 
 

EC grant: FP7 HEALTH

Grant agreement: 223131

Total grant: 9.988.092 Eur

Project information

EuResist Network GEIE
Via Guido Guinizelli, 98/100 - 00152 Rome - Italy
Tel. +39 065882352 

VAT N. 09950311002 / reg. N° RM-1199300

email: info@euresist.org

Follow us on ​LinkedIn


 

CEO: Dr. Francesca Incardona

e-mail: f.incardona@euresist.org

EuResist Network GEIE | © 2017-2022 All Right Reserved

The EuResist Network is open to new partners of proved or potential scientific value for expanding both database and scientific programme. Co-operation with developing countries with high rates of HIV infections is mostly welcome.

All the partners have one representative in the EuResist Network Scientific Board. The Board evaluates requests to access the EIDB for scientific studies. Partner's activities and data are protected by the data and authorship policy.

bottom of page